参考文献

[1] Xiao B, Wang L N, Li W, et al. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis[J]. Cell death & disease, 2018, 9(5): 533. （IF：5.959 锐博产品：miRNA mimic 研究领域：肾小球硬化血浆miRNA生物标志物 第三军医大学）

[2] Lu Z, He Q, Liang J, et al. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer[J]. Molecular Therapy-Nucleic Acids, 2019, 16: 471-480. （IF：5.919 锐博产品：miRNA mimic、antagomir、转染试剂 研究领域：口腔癌 中山大学附属第一医院）

[3] Huang L, Wang Y, Chen J, et al. Long noncoding RNA PCAT1, a novel serum-based biomarker, enhances cell growth by sponging miR-326 in oesophageal squamous cell carcinoma[J]. Cell death & disease, 2019, 10(7): 513. （IF：5.959 锐博产品：mimic、外泌体抽提试剂盒 研究领域：食管鳞状上皮癌 大连医科大学）

[4] Zhao L, Wang W, Xu L, et al. Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancer[J]. Oncogene, 2019, 38(13): 2305. （IF：6.634 锐博服务：mimic & inhibitor、antagomir 研究领域：卵巢癌 四川大学）

[5] Mu N, Gu J, Liu N, et al. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways[J]. Theranostics, 2018, 8(6): 1527. （IF：8.063 锐博产品：EdU 研究领域：胶质母细胞瘤 第四军医大学）